A single arm, open-label, multicenter, multinational, safety and efficacy Phase IIIb trial of BI 695502 plus mFOLFOX6 in patients with previously untreated metastatic colorectal cancer

Type of Cancer
Multiple Myeloma

Site
Bethesda

Sponsor
Boehringer Ingelheim Pharma

Protocol Number
1302.3

To Learn More Call
201-510-0910